Aquestive Therapeutics Statistics

Total Valuation

AQST has a market cap or net worth of $499.16 million. The enterprise value is $419.26 million.

Market Cap	499.16M
Enterprise Value	419.26M

Important Dates

The next estimated earnings date is Friday, May 1, 2026, after market close.

Earnings Date	May 1, 2026
Ex-Dividend Date	n/a

Share Statistics

AQST has 122.05 million shares outstanding. The number of shares has increased by 23.29% in one year.

Current Share Class	122.05M
Shares Outstanding	122.05M
Shares Change (YoY)	+23.29%
Shares Change (QoQ)	+10.29%
Owned by Insiders (%)	3.37%
Owned by Institutions (%)	56.90%
Float	111.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.18
Forward PS	10.16
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.41
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.14

Current Ratio	3.14
Quick Ratio	2.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-33.92%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-62.98%
Weighted Average Cost of Capital (WACC)	14.19%
Revenue Per Employee	$303,027
Profits Per Employee	-$569,959
Employee Count	147
Asset Turnover	0.34
Inventory Turnover	3.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.51% in the last 52 weeks. The beta is 1.53, so AQST's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+42.51%
50-Day Moving Average	4.12
200-Day Moving Average	4.86
Relative Strength Index (RSI)	47.08
Average Volume (20 Days)	1,112,571

Short Selling Information

The latest short interest is 15.52 million, so 12.72% of the outstanding shares have been sold short.

Short Interest	15.52M
Short Previous Month	17.56M
Short % of Shares Out	12.72%
Short % of Float	13.90%
Short Ratio (days to cover)	11.00

Income Statement

In the last 12 months, AQST had revenue of $44.55 million and -$83.78 million in losses. Loss per share was -$0.78.

Revenue	44.55M
Gross Profit	25.99M
Operating Income	-71.05M
Pretax Income	-83.78M
Net Income	-83.78M
EBITDA	-70.48M
EBIT	-71.05M
Loss Per Share	-$0.78

Full Income Statement

Balance Sheet

The company has $121.17 million in cash and $42.48 million in debt, giving a net cash position of $78.69 million or $0.64 per share.

Cash & Cash Equivalents	121.17M
Total Debt	42.48M
Net Cash	78.69M
Net Cash Per Share	$0.64
Equity (Book Value)	-33.66M
Book Value Per Share	-0.28
Working Capital	101.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$52.43 million and capital expenditures -$562,000, giving a free cash flow of -$52.99 million.

Operating Cash Flow	-52.43M
Capital Expenditures	-562,000
Depreciation & Amortization	574,000
Net Borrowing	-26,000
Free Cash Flow	-52.99M
FCF Per Share	-$0.43

Full Cash Flow Statement

Margins

Gross margin is 58.35%, with operating and profit margins of -159.50% and -188.09%.

Gross Margin	58.35%
Operating Margin	-159.50%
Pretax Margin	-188.09%
Profit Margin	-188.09%
EBITDA Margin	-158.22%
EBIT Margin	-159.50%
FCF Margin	n/a

Dividends & Yields

AQST does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.29%
Shareholder Yield	-23.29%
Earnings Yield	-16.83%
FCF Yield	-10.64%

Analyst Forecast

The average price target for AQST is $9.00, which is 120.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	120.05%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	38.91%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AQST has an Altman Z-Score of -2.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.92
Piotroski F-Score	2